Back to Search Start Over

More than Drug Fever: Dexmedetomidine-Induced Hyperthermia in a Critically Ill Patient.

Authors :
Kressin CL
Bensadoun E
James W
Lawless B
Kellum B
Flannery AH
Source :
Journal of pharmacy practice [J Pharm Pract] 2023 Aug; Vol. 36 (4), pp. 1026-1029. Date of Electronic Publication: 2022 Apr 14.
Publication Year :
2023

Abstract

Dexmedetomidine is a selective alpha-2 adrenergic agonist utilized for sedation in critically ill patients. <superscript>1</superscript> We present the case of a morbidly obese critically ill patient who experienced profound hyperthermia, with a maximum temperature of 41.4°C, hours after starting a dexmedetomidine infusion that was otherwise not explained by her clinical diagnoses. The hyperthermia resolved hours following cessation of the infusion. Dexmedetomidine was assessed as probable in terms of causing this adverse effect. Dexmedetomidine may be associated not only with low-grade fever, but as demonstrated in our case, it may be associated with significant temperature elevations requiring cessation of therapy to restore normothermia.

Details

Language :
English
ISSN :
1531-1937
Volume :
36
Issue :
4
Database :
MEDLINE
Journal :
Journal of pharmacy practice
Publication Type :
Academic Journal
Accession number :
35421323
Full Text :
https://doi.org/10.1177/08971900221087948